Showing results (171-180 of 353) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|May 11, 2021
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)Mathias J Rummel, Ann Janssens, David MacDonald, et al.
Clinical Immunology (Orlando, Fla.)|September 30, 2006
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogenyJennifer H Anolik, Jonathan W Friedberg, Bo Zheng, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2018
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center ExperienceAnnaLynn M Williams, Andrea M Baran, Carla Casulo, et al.
Journal of General Internal Medicine|November 15, 2014
Nudging physician prescription decisions by partitioning the order set: results of a vignette-based studyDavid Tannenbaum, Jason N Doctor, Stephen D Persell, et al.
Journal of General Internal Medicine|March 5, 2020
Clinician-Level Variation in Three Measures Representing Overuse Based on the American Geriatrics Society Choosing Wisely StatementTheresa A Rowe, Tiffany Brown, Ji Young Lee, et al.
BMC Health Services Research|January 27, 2018
Utilization of health care services among Medicare beneficiaries who visit federally qualified health centersTara A Lavelle, Adam J Rose, Justin W Timbie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2007
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804N L Bartlett, D Niedzwiecki, J L Johnson, et al.
Rand Health Quarterly|August 4, 2020
Effects of Health Care Payment Models on Physician Practice in the United States: Follow-Up StudyMark W Friedberg, Peggy G Chen, Molly Simmons, et al.
Pageof 36